Fluoxetine is a selective serotonin reuptake inhibitor (SSRI) that functions by inhibiting the neuronal mechanism responsible for recapturing synaptic serotonin, thereby increasing its concentration in the cleft to treat mood disorders and related psychiatric conditions within the domain of psychopharmacology. The therapeutic efficacy of this class of agents involves distinct kinetic principles governing dose titration timelines and necessitates strict adherence to washout periods due to the risk of life-threatening drug interactions such as serotonin syndrome when combined with monoamine oxidase inhibitors or other serotonergic agents. This theoretical framework operates under formal classification systems regarding pregnancy safety categories, lactation transfer risks, and contraindicated concurrent therapies that define clinical boundaries for antidepressant management.
Fluoxetine is a selective serotonin reuptake inhibitor (SSRI) that functions by inhibiting the neuronal mechanism responsible for recapturing synaptic serotonin, thereby increasing its concentration …